Related Articles
Lapatinib enhances trastuzumab-mediated antibody-dependent cellular cytotoxicity via upregulation of HER2 in malignant mesothelioma cells
Anti‑tumor effect of neratinib against lung cancer cells harboring HER2 oncogene alterations
Androgen-independent prostate cancer cells circumvent EGFR inhibition by overexpression of alternative HER receptors and ligands
Expression of fibroblast growth factor and FGF-receptor family genes in human myeloma cells, including lines possessing t(4;14)(q16.3;q32. 3) and FGFR3 translocation.
Synergistic inhibitory effects of an engineered antibody‑like molecule ATF‑Fc and trastuzumab on tumor growth and invasion in a human breast cancer xenograft mouse model